Economic value of extended-window intravenous alteplase in posterior circulation stroke: a Markov analysis based on the EXPECTS trial.

Ma Y, Lou Y, Chen M, Zeng Y

Open source

DOI
10.3389/fphar.2025.1734165
Published
2025
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1734165,
  title = {Economic value of extended-window intravenous alteplase in posterior circulation stroke: a Markov analysis based on the EXPECTS trial.},
  author = {Ma Y and Lou Y and Chen M and Zeng Y},
  year = {2025},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2025.1734165},
  url = {https://doi.org/10.3389/fphar.2025.1734165}
}

RIS

TY  - JOUR
TI  - Economic value of extended-window intravenous alteplase in posterior circulation stroke: a Markov analysis based on the EXPECTS trial.
AU  - Ma Y
AU  - Lou Y
AU  - Chen M
AU  - Zeng Y
PY  - 2025
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2025.1734165
UR  - https://doi.org/10.3389/fphar.2025.1734165
ER  - 

APA

Y, M., Y, L., M, C., & Y, Z. (2025). Economic value of extended-window intravenous alteplase in posterior circulation stroke: a Markov analysis based on the EXPECTS trial.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2025.1734165

Source records